ALTIUS
The ‘very practical’ team at ALTIUS counts innovative companies in the pharma industry, as well as hospitals, private equity investors, and leading groups from the dental and veterinary spheres among its key clients. Christophe Ronse brings his IP expertise to bear on relevant life sciences work, while Philippe de Jong has extensive regulatory experience.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Extremely deep knowledge of the subject and really ready to share the key points so that in-house and external legal teams can optimise quality service.’
‘Clear, no-nonsense, quick advice provided in a friendly and accessible way.’
‘Very practical, translating the law to clear advice.’
‘Fast and correct advice.’
Key clients
- AbbVie
- P3Lab
- Hipra
- Organon
- Applied Medical
- Beiersdorf
- Bayer
- Merck (MSD)
Work highlights
- Assisted the The European Mirocals Consortium (Horizon 2020 EU Project) with the negotiation of a worldwide exclusive license agreement (including clinical trial results) with ILTOO Pharma.
- Advised Hipra on the implementation of new EU Regulation 2019/6.
- Advised Merck Sharp & Dohme on the impact of anti-tampering devices under the Falsified Medicines Directive on the parallel import of medicines.
Practice head
The lawyer(s) leading their teams.
Christophe Ronse, Philippe de Jong